University of Iowa Health Care picks Zingbox to monitor its IoT medical devices
Through its IoT Guardian solution, Zingbox provides real-time risk assessment across the health system's network of more than 45,000 connected medical devices.
Through its IoT Guardian solution, Zingbox provides real-time risk assessment across the health system's network of more than 45,000 connected medical devices.
The company's technology for screening diabetic retinopathy was granted "Breakthrough Device" designation and is able to provide a clinical decision, instead of simply a recommendation to the physician.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The marketing clearance follows the FDA's decision to approve a "breakthrough device" designation for IDx-DR, accelerating the review process for the product based on its ability to address an unmet medical need.